Pimecrolimus cream is a prescription non-steroidal medication in the class of topical calcineurin inhibitors (TCIs). It is FDA-approved for the treatment of mild to moderate atopic dermatitis. This article will discuss the mechanism of action, administration, adverse effects, contraindications, monitoring, and theoretical toxicity associated with topical pimecrolimus that is pertinent to members of the healthcare team in the care of patients with atopic dermatitis and other inflammatory skin conditions.

**Objectives:**
- Describe the use of topical steroids and the ancillary role of topical calcineurin inhibitors.
- Summarize the use of pimecrolimus in the treatment of atopic dermatitis and other selected inflammatory dermatoses.
- Review the mechanism of action of pimecrolimus.
- Explain the theoretical risk for toxicity and how appropriate counseling provided by members of the healthcare team can provide reassurance and improve outcomes for patients using topical pimecrolimus.